EUVIMEDEUVIMED entdecken
Open Access

Can Polygenic Risk Scores for Metabolic Syndrome Contribute to Long-Term Syndrome Development in First-Episode Psychosis Patients? A Naturalistic 21-Year Follow-Up Study

Manuel J Cuesta iD, Sergi Papiol, Eloi Giné-Servén, Alejandro Ballesteros, Gustavo J Gil-Berrozpe iD, David Peralta, Benedicto Crespo-Facorro, Ana M Sánchez-Torres iD, Victor Peralta, SEGPEPs group

Schizophrenia Bulletin · 2025

DOI: 10.1093/schbul/sbaf158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2025. Verfasst von Manuel J Cuesta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Hospital Universitario de Navarra, 31008, Pamplona, Spain. Hauptthemen laut MEDLINE: Metabolic Syndrome, Psychotic Disorders, Waist Circumference, Schizophrenia. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Psych-STRATA project, Carlos III Health Institute (FEDER Funds), Government of Navarra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Metabolic syndrome (MetS) is still a challenge for clinicians treating patients with first-episode psychosis (FEP). Study Design We explored whether polygenic risk scores for MetS (PRSMetS) may be associated with MetS in FEP patients. The sample comprised 164 FEP patients who were followed-up for a mean of 20.9 years. MetS was defined according to the ATP III criteria at the end of the follow-up. We used logistic regression models to examine the contribution of PRSs for the development of MetS and associated metabolic symptoms after allowing for the effect of covariates. Furthermore, we investigated the relationships between PRSMetS and metabolic symptoms using network analysis (NA). Study Results PRSMetS significantly contributed to the development of MetS and the increase of waist circumference at the long-term follow-up, accounting for 7.9% and 6.8% of the explained variance, respectively. Moreover, the PRS of high-density lipoprotein cholesterol levels showed a significant association value for hypertension, accounting for 5.6% of the variance. PRSMetS showed a significant linear trend with the number of MetS criteria and this trend remained significant after allowing for standard epidemiological and clinical baseline variables in the hierarchical multiple regression analysis. PRSMetS, PRSWaist, and the five metabolic criteria showed rich interconnections in the network analysis. Conclusions MetS PRSs showed significant relationships with metabolic disturbances in patients with FEP over a lifetime. Our findings may offer promising avenues for the PRSMetS to be integrated with relevant clinical measures for identifying the FEP patients most vulnerable to develop MetS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromePsychotic DisordersWaist CircumferenceSchizophreniaHypertensionHumansGenetic Risk ScoreFollow-Up StudiesAdultMaleFemaleYoung AdultAdolescentMultifactorial Inheritance

Stichwörter der Autor:innen

first-episode psychosislong-term outcomemetabolic syndromenetwork analysispolygenic risk scores

Autor:innen und Institutionen

  • Department of Psychiatry, Hospital Universitario de Navarra, 31008, Pamplona, Spain.
  • Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008, Pamplona, Spain.
  • Network Center for Biomedical Research in Mental Health (CIBER of Mental Health, CIBERSAM), 28029, Madrid, Spain.
  • Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
  • Max Planck Institute of Psychiatry, Munich 80804 Germany.
  • Mental Health Department, Servicio Navarro de Salud, 31003, Pamplona, Spain.

ORCID-Profile: Manuel J Cuesta, Gustavo J Gil-Berrozpe, Ana M Sánchez-Torres

Förderung

  • Psych-STRATA project
  • Carlos III Health Institute (FEDER Funds)
  • Government of Navarra

Zitieren

APA

Cuesta, M. J., Papiol, S., Giné-Servén, E., Ballesteros, A., Gil-Berrozpe, G. J., Peralta, D., Crespo-Facorro, B., Sánchez-Torres, A. M., Peralta, V., & SEGPEPs group (2025). Can Polygenic Risk Scores for Metabolic Syndrome Contribute to Long-Term Syndrome Development in First-Episode Psychosis Patients? A Naturalistic 21-Year Follow-Up Study. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf158

Vancouver

Cuesta MJ, Papiol S, Giné-Servén E, Ballesteros A, Gil-Berrozpe GJ, Peralta D, et al. Can Polygenic Risk Scores for Metabolic Syndrome Contribute to Long-Term Syndrome Development in First-Episode Psychosis Patients? A Naturalistic 21-Year Follow-Up Study. Schizophrenia Bulletin. 2025. doi:10.1093/schbul/sbaf158

BibTeX
@article{Cuesta2025,
  author = {Cuesta, Manuel J and Papiol, Sergi and Giné-Servén, Eloi and Ballesteros, Alejandro and Gil-Berrozpe, Gustavo J and Peralta, David and Crespo-Facorro, Benedicto and Sánchez-Torres, Ana M and Peralta, Victor and SEGPEPs group, SEGPEPs group},
  title = {Can Polygenic Risk Scores for Metabolic Syndrome Contribute to Long-Term Syndrome Development in First-Episode Psychosis Patients? A Naturalistic 21-Year Follow-Up Study},
  journal = {Schizophrenia Bulletin},
  year = {2025},
  doi = {10.1093/schbul/sbaf158}
}
Kostenlos starten →